Tobacco Use Disorder Outcomes Wang, Volkow, and colleagues also conducted a study of 222,942 individuals with tobacco use disorder and type 2 diabetes, with findings showing individuals prescribed semaglutide showed a 32% lower risk of tobacco-related healthcare visits and were less likely to need smoking cessation medications or counseling during the 12-month follow-up period, with the most notable effects appearing within the first 30 days (Wang et al., 2024c)
Before moving to that stage, Judge Marston directed both sides to resolve several issues with broad implications for the litigation, including those of preemption and general causation
Kathleen Corey has received grant funding from BMS and Boehringer Ingelheim as well as fees for consulting from Gilead and Novo Nordisk, unrelated to the current project
"We wanted to make sure that we stayed on message: This was a temporary thing and the goal is to taper off the drugs and [not to] stay on GLP-1s permanently," says a former Calibrate health coach, who worked with several hundred of the company's customers during her time at the company, but asked for anonymity in order to discuss her former employer
The CD55 + THY1 PDPN + CD34 FLS phenotype, which is restricted to the lining layer, is predominant in OA
Now, many patients are facing difficult choices
